Provider advocates celebrated—with some reservations—the recently issued final rule reshaping the Administrative Dispute Resolution (ADR) process for 340B stakeholders. On [...] …
Category: Pharma Industry
Drugmakers AbbVie and Boehringer Ingelheim (BI) have agreed in principle to exempt Arkansas providers from their 340B contract pharmacy restrictions, [...] …
Merck has added an injectable medication used to treat pulmonary arterial hypertension—a type of high blood pressure which affects the [...] …
Breaking News
HRSA Issues Final Regulations Revamping Process to Resolve Disputes Between 340B Providers and Manufacturers
The federal government issued the final rule early Thursday to implement a long-anticipated revision to the 340B Administrative Dispute Resolution [...] …
After missing its self-imposed deadline of the end of 2023, the White House this week completed its review to implement [...] …
An influential drug industry trade group has asked a full federal appeals court to rehear a case on the constitutionality [...] …
Drug manufacturer AbbVie recently replied to Louisiana’s request for summary judgement and defended its own such request in its ongoing [...] …
A federal district court has transferred drugmaker AstraZeneca’s lawsuit challenging Arkansas’ 340B contract pharmacy access law to a judge who [...] …
A recent analysis of the increasing annual total number of drug manufacturer refunds to 340B covered entities notes they are [...] …
Drug manufacturer Teva this week added a blood therapy medication to its hospital contract pharmacy restrictions implemented last summer. The [...] …